GlassScriptPhysician profile
Krista Lynd Jacobs
NPI 1730839028
$9,291.10
in general payments reported to CMS, 2019-2025
26 companies · $1,831 in 2025
The $1,831 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,140 · 2023: $2,734 · 2024: $1,586 · 2025: $1,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,592 · Travel and Lodging: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,591.98 |
| Travel and Lodging | $558.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,840.09 | 2022-2025 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
| Abbott Laboratories | $1,164.34 | 2023-2025 | Proclaim, Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $486.59 | 2022-2025 | Relistor, Trulance |
| Relievant Medsystems, INC. | $424.39 | 2023 | Intracept |
| Collegium Pharmaceutical, INC. | $397.91 | 2022-2025 | Belbuca, Xtampza |
| Abbvie INC. | $354.44 | 2022-2025 | |
| Tersera Therapeutics LLC | $227.82 | 2022-2023 | Prialt |
| Vertos Medical, INC. | $198.16 | 2022-2024 | Mild Device Kit |
| Globus Medical, INC. | $191.91 | 2025 | Senza |
| Spinal Simplicity, LLC | $183.64 | 2025 | Ha Minuteman G3-R |
| Mml US, INC. | $169.74 | 2023 | Reactiv8 |
| Scilex Pharmaceuticals INC. | $157.27 | 2022-2024 | Ztlido |
| Pfizer INC. | $104.93 | 2023-2025 | |
| Boston Scientific Corporation | $87.28 | 2024-2025 | Intracept |
| Grt US Holding, INC. | $54.95 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $38.69 | 2022 | |
| Amgen INC. | $34.33 | 2022 | |
| Si-Bone, INC. | $25.32 | 2025 | |
| Protega Pharmaceutials INC | $24.86 | 2025 | Roxybond |
| Averitas Pharma INC. | $24.77 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $22.57 | 2025 | |
| Impel Pharmaceuticals INC. | $20.25 | 2023 | Trudhesa |
| Convatec INC. | $16.06 | 2024 | |
| Bioventus LLC | $15.19 | 2023 | Supartz Fx Sodium Hyaluronate |
| Sanofi-Aventis U.S. LLC | $12.97 | 2023 | |
| Redhill Biopharma INC. | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.